Flow cytometric analysis of DNA ploidy in large cleaved cell lymphomas

Area of Science:

• Oncology
• Hematology
• Molecular Biology

Background:

• Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoid malignancies.
• Follicular centre cell lymphomas represent a significant subtype requiring prognostic markers.
• Nuclear DNA content analysis offers insights into cellular proliferation and genetic stability.

Purpose of the Study:

• To investigate the DNA ploidy and S phase percentage in large cleaved follicular centre cell non-Hodgkin's lymphomas (NHL).
• To assess the correlation between DNA content, S phase fraction, and patient prognosis.
• To compare these findings with intermediate and high-grade NHLs.

Main Methods:

• Nuclear DNA content was analyzed in 28 patients with large cleaved follicular centre cell NHL.
• Flow cytometry was used to determine DNA aneuploidy and S phase percentage (SPF).
• Statistical analysis was performed to correlate ploidy and SPF with survival outcomes.

Main Results:

• DNA aneuploidy was detected in 11 (39%) of the cases, with DNA indices ranging from 1.14 to 2.28.
• Seven (25%) cases exhibited tetraploidy.
• DNA ploidy status was not significantly associated with prognosis.
• A higher S phase percentage (SPF > 9.7%) showed a non-significant trend towards poorer survival.

Conclusions:

• DNA aneuploidy and tetraploidy are common findings in large cleaved follicular centre cell NHL.
• Nuclear DNA content (ploidy) does not appear to be a reliable prognostic factor in this NHL subtype.
• While not statistically significant, S phase percentage warrants further investigation as a potential prognostic indicator.